Lung Cancer Clinical Trial
Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer
Summary
This study is for patients with advanced non small cell lung cancer that has progressed despite standard of care. The purpose of the study is to see if Kanglaite injection has any effect on survival.
Eligibility Criteria
Inclusion Criteria:
confirmed (within last 3 months)progressive Stage IV NSCLC
estimated life span of 3 months
phase angle of at least 5 as measured by bioimpedance
Exclusion Criteria:
currently taking a lipid lowering medications
has an imminently life threatening condition
has pre-existing liver disease
known allergy to soybeans
uncontrolled diabetes or uncontrolled disturbance of lipid metabolism
pregnant or lactating
has a pacemaker or other implantable electronic medical device
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Memphis Tennessee, 38120, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.